Skye Bioscience Inc
SKYE
$2.05-0.12 (-5.53%)
Jun 13, 2025, 4:00 PM
Financials
| 52Week High | 11.16 | 52Week Low | 1.14 |
| Beta | 1.94 | Current Ratio Annual | 16.32 |
| Current Ratio Quarterly | 11.85 | Gross Margin TTM | 39.29 |
| Market Cap | 63.52M | Net Profit Margin TTM | -3.57 |
| Operating Margin TTM | -7.14 | Price To Book | 1.07 |
| Price To Sales TTM | 226.85 | Quick Ratio Annual | 16.28 |
| Quick Ratio Quarterly | 11.74 | Return On Assets TTM | -42.63 |
| Return On Equity TTM | -47.32 | Return On Investment TTM | -46.50 |
| Revenue Per Share TTM | 0.00 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 74 | 0 | 2 | 1 | 2 | 4 | 25.21M | $71.04M |
| Mar 31, 2025 | 76 | 12 | 6 | 17 | 19 | 25 | 24.77M | $39.34M |
| Change | 2(3%) | 12 | 4(200%) | 16(1600%) | 17(850%) | 21(525%) | 441.81K(2%) | $31.71M(45%) |